Literature DB >> 16567538

Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes.

Max Nieuwdorp1, Hans L Mooij, Jojanneke Kroon, Bektas Atasever, Jos A E Spaan, Can Ince, Frits Holleman, Michaela Diamant, Robert J Heine, Joost B L Hoekstra, John J P Kastelein, Erik S G Stroes, Hans Vink.   

Abstract

Chronic hyperglycemia underlies microvascular complications in patients with type 1 diabetes. The mechanisms leading to these vascular complications are not fully understood. Recently, we observed that acute hyperglycemia results in endothelial glycocalyx damage. To establish whether glycocalyx is associated with microvascular damage, we performed glycocalyx perturbation volume measurements in type 1 diabetic patients with microalbuminuria (DM1-MA group; n = 7), without microalbuminuria (DM1-NA group; n = 7), and in age-matched control subjects (CON; n = 7). Systemic glycocalyx volume was determined comparing intravascular distribution volume of a glycocalyx-permeable tracer (dextran 40) to that of a glycocalyx-impermeable tracer (labeled erythrocytes). Sublingual capillaries were visualized using orthogonal polarization spectral microscopy to estimate microvascular glycocalyx. Patients and control subjects were matched according to age and BMI. Glycocalyx volume decreased in a stepwise fashion from CON, DM1-NA, and finally DM1-MA subjects (1.5 +/- 0.1, 0.8 +/- 0.4, and 0.2 +/- 0.1 l, respectively, P < 0.05). Microvascular glycocalyx in sublingual capillaries was also decreased in type 1 diabetes versus the control group (0.5 +/- 0.1 vs. 0.9 +/- 0.1 microm, P < 0.05). Plasma hyaluronan, a principal glycocalyx constituent, and hyaluronidase were increased in type 1 diabetes. In conclusion, type 1 diabetic patients are characterized by endothelial glycocalyx damage, the severity of which is increased in presence of microalbuminuria.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16567538     DOI: 10.2337/diabetes.55.04.06.db05-1619

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  141 in total

Review 1.  Endothelial dysfunction as an underlying pathophysiological condition of chronic kidney disease.

Authors:  Minoru Satoh
Journal:  Clin Exp Nephrol       Date:  2012-06-06       Impact factor: 2.801

2.  High glucose causes dysfunction of the human glomerular endothelial glycocalyx.

Authors:  A Singh; V Fridén; I Dasgupta; R R Foster; G I Welsh; J E Tooke; B Haraldsson; P W Mathieson; S C Satchell
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-27

Review 3.  Endothelial glycocalyx: permeability barrier and mechanosensor.

Authors:  F E Curry; R H Adamson
Journal:  Ann Biomed Eng       Date:  2011-10-19       Impact factor: 3.934

Review 4.  The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD.

Authors:  Michaela Diamant; Maarten E Tushuizen
Journal:  Curr Diab Rep       Date:  2006-08       Impact factor: 4.810

Review 5.  The endothelial glycocalyx: composition, functions, and visualization.

Authors:  Sietze Reitsma; Dick W Slaaf; Hans Vink; Marc A M J van Zandvoort; Mirjam G A oude Egbrink
Journal:  Pflugers Arch       Date:  2007-01-26       Impact factor: 3.657

6.  Erythrocyte flow in choriocapillaris of normal and diabetic rats.

Authors:  Rod D Braun; Christopher A Wienczewski; Asad Abbas
Journal:  Microvasc Res       Date:  2009-03-06       Impact factor: 3.514

7.  Advanced age results in a diminished endothelial glycocalyx.

Authors:  Daniel R Machin; Samuel I Bloom; Robert A Campbell; Tam T T Phuong; Phillip E Gates; Lisa A Lesniewski; Matthew T Rondina; Anthony J Donato
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-05-11       Impact factor: 4.733

8.  Endothelial barrier dysfunction in diabetic conduit arteries: a novel method to quantify filtration.

Authors:  Xiao Lu; Virginia H Huxley; Ghassan S Kassab
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-07       Impact factor: 4.733

9.  Effect of anticoagulants on the plasma hyaluronidase activities.

Authors:  R Sharma; Y H Mahadeswaraswamy; K Harish Kumar; S Devaraja; K Kemparaju; B S Vishwanath; K S Girish
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

10.  Non-purine selective xanthine oxidase inhibitor ameliorates glomerular endothelial injury in InsAkita diabetic mice.

Authors:  Seiji Itano; Hiroyuki Kadoya; Minoru Satoh; Takashi Nakamura; Takayo Murase; Tamaki Sasaki; Yashpal S Kanwar; Naoki Kashihara
Journal:  Am J Physiol Renal Physiol       Date:  2020-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.